WallStreetZenWallStreetZen

NASDAQ: TCBP
Tc Biopharm PLC Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

TCBP past revenue growth

How has TCBP's revenue growth performed historically?
Company
75.57%
Industry
69.21%
Market
13.96%
TCBP's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
TCBP's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
TCBP's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

TCBP earnings and revenue history

Current Revenue
$4.6M
Current Earnings
-$1.7M
Current Profit Margin
-36.1%

TCBP Return on Equity

Insufficient data to display

Be the first to know when TCBP announces earnings.

TCBP Return on Assets

Current Company
-14.6%
Current Industry
0.2%
TCBP is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

TCBP Return on Capital Employed

Current Company
217.42%
Current Industry
12.2%
TCBP has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

TCBP vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
TCBP$4.81M$6.06M-$1.74M+30.10%N/A
NBY$13.64M-$11.82M-$17.89M-4.84%N/A
CMND$0.00N/A-$9.81MN/AN/A
ONCS$0.00-$31.73M-$29.39MN/AN/A
PTE$73.00k-$7.14M-$8.31M-99.52%N/A
View Top Biotech Stocks

Tc Biopharm Earnings & Revenue FAQ

What were TCBP's earnings last quarter?

Tc Biopharm (NASDAQ: TCBP) reported Q4 2022 earnings per share (EPS) of N/A, up N/A year over year. Total Tc Biopharm earnings for the quarter were N/A. In the same quarter last year, Tc Biopharm's earnings per share (EPS) was -$13.01.

If you're new to stock investing, here's how to buy Tc Biopharm stock.

What was TCBP's earnings growth in the past year?

As of Q2 2023, Tc Biopharm's earnings has grown year over year. Tc Biopharm's earnings in the past year totalled -$1.74 million.

What was TCBP's revenue last quarter?

Tc Biopharm (NASDAQ: TCBP) reported Q4 2022 revenue of N/A up N/A year over year. In the same quarter last year, Tc Biopharm's revenue was $659.55 thousand.

What was TCBP's revenue growth in the past year?

As of Q2 2023, Tc Biopharm's revenue has grown 75.57% year over year. This is 6.36 percentage points higher than the US Biotechnology industry revenue growth rate of 69.21%. Tc Biopharm's revenue in the past year totalled $4.81 million.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.